Pallavi Kumar, MD, MPH
Assistant Professor of Clinical Medicine
Department: Medicine
Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-200
3400 Civic Center Blvd
Philadelphia, PA 19104
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-200
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-360-0737
Fax: 215-615-5122
Fax: 215-615-5122
Education:
BS (Accounting)
Binghamton University, 1999.
MD (Medicine)
Duke University, Durham NC, 2007.
MPH (Clinical Effectiveness)
Harvard School of Public Health, 2014.
Permanent linkBS (Accounting)
Binghamton University, 1999.
MD (Medicine)
Duke University, Durham NC, 2007.
MPH (Clinical Effectiveness)
Harvard School of Public Health, 2014.
Description of Clinical Expertise
palliative medicinethoracic oncology
gastrointestinal oncology
Description of Other Expertise
Serious Illness Care Program - faculty training and program implementationDescription of Research Expertise
Health Services Research - palliative care integration into oncology careHealth Services Research - serious illness communication
Selected Publications
a. Kumar P, Wixon-Genack J, Kavanagh J, Sanders JJ, Paladino J, O'Connor NR. : Serious Illness Conversations With Outpatient Oncology Clinicians: Understanding the Patient Experience. JCO Oncol Pract. August 2020.Perez GK, Gareen IF, Sicks J, Lathan C, Carr A, Kumar P, Ponzani C, Hyland K, Park ER. : Racial Differences in Smoking-related Disease Risk Perceptions Among Adults Completing Lung Cancer Screening: Follow-up Results from the ACRIN/NLST Ancillary Study. J Racial Ethn Health Disparities. 6(4): 676-685, Aug 2019.
Japuntich SJ, Kumar P, Pendergast JF, Juarez Caballero GY, Malin JL, Wallace RB, Chrischilles EA, Keating NL, Park ER. : Smoking Status and Survival Among a National Cohort of Lung and Colorectal Cancer Patients. Nicotine Tob Res. 21(4): 497-504, Mar 2019.
Orr AR, Lefler D, Deshpande C, Kumar P. : Extranodal Rosai-Dorfman Disease Presenting as a Mediastinal Mass with Pulmonary Artery Invasion. Case Rep Hematol. 12: 3915319, Apr 2018.
Kumar P, Wright AA, Hatfield LA, Temel JS, Keating NL. : Family Perspectives on Hospice Care Experiences of Patients with Cancer. J Clin Oncol. 35(4): 432-439, Feb 2017.
Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER.: Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. Oncologist. Bruce A. Chabner (eds.). Alphamed Press, 21(1): 40-49, Jan 2016.
Kumar P, Hatfield L, Wright A, Temel J, Keating N. : Associations between hospice use and end-of-life (EOL) care outcomes in patients with advanced cancer - A National, Prospective Cohort Study American Society of Clinical Oncology (ASCO) - 2015 Palliative Care in Oncology Symposium American Society of Clinical Oncology, 33(29): suppl 29S, Oct 2015 Notes: Poster Discussion Session, Palliative Care in Oncology Symposium
Kumar P, Sullivan RJ.: The Ethics of Randomized Trials in Oncology. BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery. Ryan J. Sullivan (eds.). Springer-Verlag New York, 82: 85-103, 2015.
Kumar P, Temel JS.: End-of-Life Care Discussions in Patients With Advanced Cancer. J Clin Oncol. 31(27): 3315-9, Sep 20 2013.
Kumar P, Moy B.: Cancer Health Disparities and the Cost of Cancer Care: Payment Model Issues. Natl Compr Canc Netw 11(6): 633-6, Jun 1 2013.